SpeedWeed

MARCH 30, 2021

Dr Daniel Couch, Medical Lead at the UK Centre For Medicinal Cannabis welcomed the move as a sensible way of establishing an evidence base that will inform prescribing and future Randomised Controlled Trials (RCT). Private Clinic Happy To Help. “For For background on its launch see here ). Boost For NHS Cannabis Prescribing .

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

AUGUST 24, 2021

The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. Cautionary Statement Regarding Forward-Looking Statements. Investor Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. What can the current clinical trials tell us?

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

OCTOBER 5, 2021

The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. Cautionary Statement Regarding Forward-Looking Statements. Investor: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com. Media: media@mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

Cannabis Law Report

OCTOBER 19, 2021

The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 1, 2021

The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

SEPTEMBER 6, 2021

Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications. Key Topics Covered: 1 Preface. 4 Introduction.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Cannabis Law Report

SEPTEMBER 22, 2021

Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., But despite the growing popularity of CBD items, various myths surround this product that make it difficult for some individuals to make an informed decision.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Veriheal

APRIL 11, 2022

Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. federal law, from which point, informed choices can be made about the use of cannabis and cannabinoids. The post New U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. For more information, visit www.mymd.com. Dr. Chapman Bio. MyMD: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

NOVEMBER 24, 2019

Finding more information and committee details. Severe treatment-resistant epilepsy. People have the right to be involved in discussions and make informed decisions about their care, as described in your care. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. Recommendations.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

NOVEMBER 16, 2021

As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

Most official studies conducted on CBD for anxiety conclude with tentative support for CBD as an appropriate treatment for anxiety, but researchers in virtually every case suggest that more information is needed on an individual level to determine the appropriateness of using cannabis to treat anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. The coalition would strengthen the cannabis industry by informing and educating more practitioners about the mental health benefits of cannabis.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JANUARY 13, 2020

In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

CannaTech

SEPTEMBER 16, 2018

Many healthcare practitioners possess a knowledge gap about cannabis, as their medical school curriculum didn’t include any information on the topic. Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

NOVEMBER 23, 2021

The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. Cautionary Statement Regarding Forward-Looking Statements. MyMD Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

MMJ Recs

DECEMBER 22, 2023

Surveys and polls consistently show a majority of Americans supporting medical marijuana, reflecting a more informed and open-minded approach to its potential benefits. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

AUGUST 19, 2019

The Therapeutic Goods Administration (TGA), Australia’s medicines regulatory body (akin to the FDA in the USA and EMA in Europe), is currently collecting some potentially useful information from doctors prescribing medicinal cannabis around the progress of their patients.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

JANUARY 5, 2022

The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. Cautionary Statement Regarding Forward-Looking Statements. 2 Goates et al. 3 Koon Yee-Lee et al. 4 [link].

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Epilepsy & behavior case reports 9 (2018): 10. How Do CBD Drug Interactions Occur? Alsherbiny, Muhammad, and Chun Li. Medicinal Cannabis—Potential Drug Interactions.”

CBD 98

CBD THC Conditions Medicine 98

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. If these attempts failed, the information as available was utilized to include the data when applicable.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

AUGUST 26, 2021

Doctors must receive the patient’s informed consent before they can apply to the TGA to access an unapproved product. These products can only be accessed through the Special Access Scheme by an authorized healthcare practitioner, or as part of a clinical trial, according to the Office of Drug Control. Costs of medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

FEBRUARY 3, 2022

CBD oils have various health benefits in treating medical disorders like epilepsy, anxiety, cancer, acne, diabetes, and others. Clinical Trials of Cannabis Are Still on Going. For more information about this report visit [link]. Oils are also used in production of creams and balms that can be absorbed through skin.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

The Joint Blog

FEBRUARY 24, 2021

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s?

Treatment 55

Treatment Clinical Trials Collective Patients 55

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Regardless all these regulatory developments, what did change, in fact?

Medicine 40

Medicine Clinical Trials Patients Access 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Epilepsy & behavior case reports 9 (2018): 10. [4] How Do CBD Drug Interactions Occur? Drug metabolism reviews 46.1 2014): 86-95. [2] Medicines 6.1 2019): 3. [3]

CBD 52

CBD THC Conditions Medicine 52

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

AUGUST 8, 2020

For more information, see: What Is Hemp & Why Does It Matter? ). Designed to treat seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome , Epidiolex is a purified (> 98% oil-based) CBD extract administered via oral spray. Why is hemp CBD illegal in some states?

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

JANUARY 24, 2022

North America Legal Cannabis Number of clinical trials. For more information about this report visit [link]. Chapter 3 North America Legal Cannabis Market: Variables, Trends & Scope. Market Segmentation. Penetration & Growth Prospect Mapping. Market Dynamics. Market Driver Analysis. Market Restraint Analysis.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., For more information, please visit www.virpaxpharma.com. About Altasciences. Christopher M.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52